elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35803226-05B337F0-C8C6-43FE-A649-D90BB5AB245E
Q35803226-05B337F0-C8C6-43FE-A649-D90BB5AB245E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803226-05B337F0-C8C6-43FE-A649-D90BB5AB245E
Pharmacological strategies to overcome HER2 cross-talk and Trastuzumab resistance.
P2860
Q35803226-05B337F0-C8C6-43FE-A649-D90BB5AB245E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35803226-05B337F0-C8C6-43FE-A649-D90BB5AB245E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0513484969c17eea9af8c3c549de7e722d33f4db
P2860
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.